Van Poznak, C., Cross, S. S., Saggese, M., Hudis, C., Panageas, K. S., Norton, L., . . . Holen, I. (2006). Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours. BMJ Group.
Citação norma ChicagoVan Poznak, C., S S. Cross, M. Saggese, C. Hudis, K S. Panageas, L. Norton, R E. Coleman, and I. Holen. Expression of Osteoprotegerin (OPG), TNF Related Apoptosis Inducing Ligand (TRAIL), and Receptor Activator of Nuclear Factor κB Ligand (RANKL) in Human Breast Tumours. BMJ Group, 2006.
Citação norma MLAVan Poznak, C., et al. Expression of Osteoprotegerin (OPG), TNF Related Apoptosis Inducing Ligand (TRAIL), and Receptor Activator of Nuclear Factor κB Ligand (RANKL) in Human Breast Tumours. BMJ Group, 2006.